← Back
Data updated: Mar 10, 2026
VALEANT PHARM INTL
DermatologyImmunologyGastroenterology
VALEANT PHARM INTL is a major pharmaceutical company focused on Dermatology, Immunology, Gastroenterology.
1952
Since
34
Drugs
-
Trials
148
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 50%
2 drugs
Immunology 25%
1 drugs
Gastroenterology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Active (3)
Discontinued (31)
ACETAMINOPHEN AND CODEINE PHOSPHATE DIPHENHYDRAMINE HYDROCHLORIDE PREDNISONE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE QUINIDINE SULFATE FOLIC ACID PREDNISOLONE TETRACYCLINE HYDROCHLORIDE AMINOPHYLLINE 8-MOP OXSORALEN RESERPINE MEPROBAMATE PROPOXYPHENE HYDROCHLORIDE DALMANE LEVO-DROMORAN PERMAX BENOQUIN SULFISOXAZOLE HYTONE TRISORALEN SODIUM PENTOBARBITAL SECOBARBITAL SODIUM FLUOXYMESTERONE ANDROID 5 ELDECORT LIBRELEASE ANDROID-F RAUWOLFIA SERPENTINA LIBRITABS BENDOPA
Company Info
- First Approval
- 1952-11-10
- Latest
- 2023-01-17
- Applications
- 42
FDA Sponsor Names
VALEANT PHARM INTLVALEANT INTL